Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp E Hartrampf

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Current Opinion in Urology|September 9, 2022
Adrenal functional imaging - which marker for which indication?Rudolf A Werner, Philipp E Hartrampf, Andreas Schirbel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 28, 2020
Pitfalls in PSMA-PET/CT: intensive bone marrow uptake in a case with polycythemia veraPhilipp E Hartrampf, Bernhard Petritsch, Andreas K Buck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 16, 2021
Intraindividual comparison of [<sup>177</sup>Lu]Lu-DOTA-EB-TATE and [<sup>177</sup>Lu]Lu-DOTA-TOCHeribert Hänscheid, Philipp E Hartrampf, Andreas Schirbel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 12, 2026
Is CXCR4 Theranostics in Oncologic, Cardiovascular, and Inflammatory Diseases Really Happening?Philipp E Hartrampf, Rudolf A Werner, Takahiro Higuchi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 28, 2019
False-negative <sup>18</sup>F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptakePhilipp E Hartrampf, Anna Katharina Seitz, Markus Krebs, et al.
Seminars in Nuclear Medicine|June 25, 2023
PSMA PET/CT for Response Assessment of <sup>177</sup>Lu-PSMA TherapyPhilipp E Hartrampf, Sebastian E Serfling, Kerstin Michalski, et al.
BMC Neurology|November 5, 2023
Complete loss of E-cadherin expression in a rare case of metastatic malignant meningioma: a case reportDominik Lisowski, Philipp E Hartrampf, Natalie Hasenauer, et al.
Radiologie (Heidelberg, Germany)|May 22, 2024
[Clinical significance of neuroendocrine tumors : Incidence, symptoms, diagnosis, stage, and prognostic factors and their influence on disease management]Philipp E Hartrampf, Sebastian E Serfling, Takahiro Higuchi, et al.
Zeitschrift Fur Medizinische Physik|September 4, 2023
PSMA-PET improves deep learning-based automated CT kidney segmentationJulian Leube, Matthias Horn, Philipp E Hartrampf, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Radiopharmaceuticals for Treatment of Adrenocortical CarcinomaKerstin Michalski, Wiebke Schlötelburg, Philipp E Hartrampf, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Current Opinion in Urology|September 9, 2022
Adrenal functional imaging - which marker for which indication?Rudolf A Werner, Philipp E Hartrampf, Andreas Schirbel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 28, 2020
Pitfalls in PSMA-PET/CT: intensive bone marrow uptake in a case with polycythemia veraPhilipp E Hartrampf, Bernhard Petritsch, Andreas K Buck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 16, 2021
Intraindividual comparison of [<sup>177</sup>Lu]Lu-DOTA-EB-TATE and [<sup>177</sup>Lu]Lu-DOTA-TOCHeribert Hänscheid, Philipp E Hartrampf, Andreas Schirbel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 12, 2026
Is CXCR4 Theranostics in Oncologic, Cardiovascular, and Inflammatory Diseases Really Happening?Philipp E Hartrampf, Rudolf A Werner, Takahiro Higuchi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 28, 2019
False-negative <sup>18</sup>F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptakePhilipp E Hartrampf, Anna Katharina Seitz, Markus Krebs, et al.
Seminars in Nuclear Medicine|June 25, 2023
PSMA PET/CT for Response Assessment of <sup>177</sup>Lu-PSMA TherapyPhilipp E Hartrampf, Sebastian E Serfling, Kerstin Michalski, et al.
BMC Neurology|November 5, 2023
Complete loss of E-cadherin expression in a rare case of metastatic malignant meningioma: a case reportDominik Lisowski, Philipp E Hartrampf, Natalie Hasenauer, et al.
Radiologie (Heidelberg, Germany)|May 22, 2024
[Clinical significance of neuroendocrine tumors : Incidence, symptoms, diagnosis, stage, and prognostic factors and their influence on disease management]Philipp E Hartrampf, Sebastian E Serfling, Takahiro Higuchi, et al.
Zeitschrift Fur Medizinische Physik|September 4, 2023
PSMA-PET improves deep learning-based automated CT kidney segmentationJulian Leube, Matthias Horn, Philipp E Hartrampf, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Radiopharmaceuticals for Treatment of Adrenocortical CarcinomaKerstin Michalski, Wiebke Schlötelburg, Philipp E Hartrampf, et al.
Pageof 8